Skip to main content
Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · Real-Time Price · USD
0.0716
-0.0066 (-8.44%)
Aug 14, 2025, 1:56 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Novel Cell Therapies
60.28M
Log In
Log In
Log In
Log In
Upgrade
Novel Cell Therapies Growth
122.05%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United Kingdom
60.28M
Log In
Log In
Log In
Log In
Upgrade
United Kingdom Growth
122.05%
Log In
Log In
Log In
Log In
Upgrade